Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.01 is 36% below its 5-year average of 4.68, near the low end of its 5-year range (0.14–26.62).
As of the fiscal period ended Friday, July 31, 2026. 20.39% below its 12-month average of 3.79.
Reported quarterly quick ratio; no daily interpolation. Q1 FY2027 (2026-07-31): 3.01.
QUICK RATIO (ACID-TEST)
3.01
QUICK RATIO (ACID-TEST) AVG TTM
3.79
QUICK RATIO (ACID-TEST) AVG 3Y
2.82
QUICK RATIO (ACID-TEST) AVG 5Y
4.68
QUICK RATIO (ACID-TEST) AVG 10Y
3.27
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-20.39%
CURRENT VS 3Y AVG
+6.96%
CURRENT VS 5Y AVG
-35.57%
CURRENT VS 10Y AVG
-7.84%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 509 covered companies
CURRENT VS SECTOR MEDIAN
+0.78%
vs the sector median at left
Alzamend Neuro Inc
Market Cap
$5.36M
Quick Ratio (Acid-Test)
3.01
TTM Avg
3.79
3Y Avg
2.82
5Y Avg
4.68
Market Cap
$5.36M
Quick Ratio (Acid-Test)
1.12
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.12
Market Cap
$5.26M
Quick Ratio (Acid-Test)
1.84
TTM Avg
1.72
3Y Avg
1.97
5Y Avg
1.97
Market Cap
$5.54M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.00
3Y Avg
0.98
5Y Avg
1.86
Market Cap
$5.59M
Quick Ratio (Acid-Test)
3.88
TTM Avg
2.19
3Y Avg
2.86
5Y Avg
5.66
Market Cap
$4.85M
Quick Ratio (Acid-Test)
5.58
TTM Avg
4.46
3Y Avg
3.04
5Y Avg
7.15
Market Cap
$4.81M
Quick Ratio (Acid-Test)
0.09
TTM Avg
0.18
3Y Avg
0.40
5Y Avg
0.95
Market Cap
$4.80M
Quick Ratio (Acid-Test)
7.22
TTM Avg
2.13
3Y Avg
2.10
5Y Avg
5.04
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alzamend Neuro Inc (ALZN) | $5.36M | 3.01 | 3.79 | 2.82 | 4.68 |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.36M | 1.12 | 0.07 | 0.07 | 0.12 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.26M | 1.84 | 1.72 | 1.97 | 1.97 |
| Imunon, Inc. (IMNN)vs › | $5.21M | 1.82 | 1.99 | 2.53 | 3.43 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.54M | 1.35 | 1.00 | 0.98 | 1.86 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | 3.88 | 2.19 | 2.86 | 5.66 |
| CalciMedica, Inc. (CALC)vs › | $4.85M | 5.58 | 4.46 | 3.04 | 7.15 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.81M | 0.09 | 0.18 | 0.40 | 0.95 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.80M | 7.22 | 2.13 | 2.10 | 5.04 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | 17.15 | 11.86 | 7.50 | 9.06 |
Quick Ratio
3.01
Excludes inventory
Current Ratio
3.01
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-07-31 | 3.01 |
| 2026-04-30 | 1.31 |
| 2026-01-31 | 1.99 |
| 2025-10-31 | 6.58 |
| 2025-07-31 | 6.03 |
| 2025-04-30 | 6.58 |
| 2025-01-31 | 5.44 |
| 2024-10-31 | 3.80 |
| 2024-07-31 | 0.49 |
| 2024-04-30 | 0.14 |
| 2024-01-31 | 0.16 |
| 2023-10-31 | 0.21 |
| 2023-07-31 | 0.88 |
| 2023-04-30 | 2.03 |
| 2023-01-31 | 3.19 |
| 2022-10-31 | 6.31 |
| 2022-07-31 | 11.78 |
| 2022-04-30 | 12.37 |
| 2022-01-31 | 26.62 |
| 2021-10-31 | 9.83 |
| 2021-07-31 | 11.41 |
| 2021-04-30 | 3.24 |
| 2021-01-31 | 0.38 |
| 2020-10-31 | 0.00 |
| 2020-07-31 | 0.00 |
| 2020-04-30 | 1.83 |
| 2020-01-31 | 0.00 |
| 2019-10-31 | 4.78 |
| 2019-07-31 | 4.78 |
| 2019-04-30 | 1.27 |
| 2019-01-31 | 1.27 |
| 2018-10-31 | 4.40 |
| 2018-07-31 | 4.40 |
| 2018-04-30 | 24.98 |
| 2018-01-31 | 24.98 |
| 2017-10-31 | 0.90 |
| 2017-07-31 | 0.90 |
| 2017-04-30 | 0.08 |
| 2017-01-31 | 0.08 |
| 2016-10-31 | 1.20 |
| 2016-07-31 | 1.20 |
